Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:00 UTC |
---|
HMDB ID | HMDB0015508 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Fencamfamine |
---|
Description | Fencamfamine (Glucoenergan, Reactivan) is a stimulant which was developed in the 1960s as an appetite suppressant, but was later withdrawn for this application due to problems with dependence and abuse. It is around half the potency of dexamphetamine, and is prescribed at a dose of 10-60mg, although abusers of the drug tend to rapidly develop tolerance and escalate their dose. Reactivan is still rarely used for treating depressive day-time fatigue, lack of concentration and lethargy, particularly in individuals who have chronic medical conditions, as its favourable safety profile makes it the most suitable drug in some cases. [Wikipedia ] |
---|
Structure | CCNC1C2CCC(C2)C1C1=CC=CC=C1 InChI=1S/C15H21N/c1-2-16-15-13-9-8-12(10-13)14(15)11-6-4-3-5-7-11/h3-7,12-16H,2,8-10H2,1H3 |
---|
Synonyms | Value | Source |
---|
2-Aethylamino-3-phenyl-nor-camphan | HMDB | Fencamfamin | HMDB | Fencamfamina | HMDB | 2-Ethylamino-3-phenylnorcamphane | HMDB | N-Ethyl-3-phenylbicyclo(2.2.1)heptan-2-amine | HMDB | Reactivan | HMDB | Fencamfamine hydrochloride | HMDB | Fencamfamine | MeSH |
|
---|
Chemical Formula | C15H21N |
---|
Average Molecular Weight | 215.3339 |
---|
Monoisotopic Molecular Weight | 215.167399677 |
---|
IUPAC Name | N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine |
---|
Traditional Name | fencamfamine |
---|
CAS Registry Number | 1209-98-9 |
---|
SMILES | CCNC1C2CCC(C2)C1C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C15H21N/c1-2-16-15-13-9-8-12(10-13)14(15)11-6-4-3-5-7-11/h3-7,12-16H,2,8-10H2,1H3 |
---|
InChI Key | IKFBPFGUINLYQI-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as bicyclic monoterpenoids. These are monoterpenoids containing exactly 2 rings, which are fused to each other. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Monoterpenoids |
---|
Direct Parent | Bicyclic monoterpenoids |
---|
Alternative Parents | |
---|
Substituents | - Bicyclic monoterpenoid
- Aromatic monoterpenoid
- Aralkylamine
- Benzenoid
- Monocyclic benzene moiety
- Secondary amine
- Secondary aliphatic amine
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Amine
- Aromatic homopolycyclic compound
|
---|
Molecular Framework | Aromatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.003 g/L | Not Available | LogP | 3.20 | SANGSTER (1994) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Fencamfamine,1TMS,isomer #1 | CCN(C1C2CCC(C2)C1C1=CC=CC=C1)[Si](C)(C)C | 1834.7 | Semi standard non polar | 33892256 | Fencamfamine,1TMS,isomer #1 | CCN(C1C2CCC(C2)C1C1=CC=CC=C1)[Si](C)(C)C | 1977.2 | Standard non polar | 33892256 | Fencamfamine,1TMS,isomer #1 | CCN(C1C2CCC(C2)C1C1=CC=CC=C1)[Si](C)(C)C | 2263.2 | Standard polar | 33892256 | Fencamfamine,1TBDMS,isomer #1 | CCN(C1C2CCC(C2)C1C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2074.6 | Semi standard non polar | 33892256 | Fencamfamine,1TBDMS,isomer #1 | CCN(C1C2CCC(C2)C1C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2215.6 | Standard non polar | 33892256 | Fencamfamine,1TBDMS,isomer #1 | CCN(C1C2CCC(C2)C1C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2425.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Fencamfamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0g2j-6910000000-0272b165bf404087b355 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fencamfamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 10V, Positive-QTOF | splash10-014i-1290000000-1061401d35301018c5ad | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 20V, Positive-QTOF | splash10-01b9-7980000000-0349f1ea830df9893202 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 40V, Positive-QTOF | splash10-00nf-9300000000-35d4a9a54b631f17acab | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 10V, Negative-QTOF | splash10-03di-0090000000-3a3e0a649a37059d1618 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 20V, Negative-QTOF | splash10-03di-1290000000-8b877af7795509948959 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 40V, Negative-QTOF | splash10-0006-9300000000-527fa30d6841f9e3199e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 10V, Positive-QTOF | splash10-014i-0090000000-c482668b0d76ffc30f05 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 20V, Positive-QTOF | splash10-014i-3390000000-e8e234a796762242b1b1 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 40V, Positive-QTOF | splash10-0006-9400000000-9aabde47aadb6e14eb6e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 10V, Negative-QTOF | splash10-03di-0090000000-96f048bbd45b899ef624 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 20V, Negative-QTOF | splash10-0229-2960000000-4efd34d61daedd5e0119 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fencamfamine 40V, Negative-QTOF | splash10-01r6-9830000000-4ba9471318e612878a1e | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - DeLucia R, Planeta CS: Fencamfamine. Gen Pharmacol. 1990;21(2):161-3. [PubMed:1970543 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
- South African Electronic Package Inserts [Link]
|
---|